ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | -98.8% | 34 | -99.1% | 0.00% | -98.5% |
| Q1 2017 | $81,000 | +2.5% | 3,877 | -7.7% | 0.07% | +103.0% |
| Q4 2016 | $79,000 | +36.2% | 4,200 | +50.0% | 0.03% | -15.4% |
| Q3 2016 | $58,000 | -49.6% | 2,800 | -37.8% | 0.04% | -54.1% |
| Q2 2016 | $115,000 | +82.5% | 4,500 | +87.5% | 0.08% | +93.2% |
| Q1 2016 | $63,000 | – | 2,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |